Tumor development was significantly delayed with median time to tumor development (≥0.1 mL tumor volume) more than doubled (33 days median, vs. 15 days) in the PPM1D-shRNA knockdown group compared to animals injected with control shRNA-transfected cells (p < 0.001) (Figure 3G). Here, PPM1D is linked to neoplasm.